GERARD SANACORA

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry NEW HAVEN, CT NPI 1992779151

General Payments — all program years on this page

$96,296.70

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 131
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $22,479.94 across 29 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $16,608.7835
2019 $8,931.0515
2020 $19,083.7323
2021 $12,057.508
2022 $4,357.505
2023 $12,778.2016
2024 $22,479.9429

Records — PY2024 (29)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077587653 Janssen Research & Development, LLC $37.30 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078846489 Janssen Scientific Affairs, LLC $3,881.25 07/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078846499 Janssen Scientific Affairs, LLC $9.76 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078846501 Janssen Scientific Affairs, LLC $9.76 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078846511 Janssen Scientific Affairs, LLC $14.00 07/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1078846519 Janssen Scientific Affairs, LLC $24.50 07/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1078846545 Janssen Scientific Affairs, LLC $55.61 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078846547 Janssen Scientific Affairs, LLC $28.05 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078846553 Janssen Scientific Affairs, LLC $24.50 07/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101252682 E.R. Squibb & Sons, L.L.C. $3,900.00 12/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118266025 Boehringer Ingelheim International GmbH $890.00 02/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118266027 Boehringer Ingelheim International GmbH $1,112.50 11/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118266029 Boehringer Ingelheim International GmbH $3,560.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118266031 Boehringer Ingelheim Pharmaceuticals, Inc. $4,895.00 07/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118266033 Boehringer Ingelheim International GmbH $209.40 08/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118266035 Boehringer Ingelheim International GmbH $217.74 08/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118266037 Boehringer Ingelheim Pharmaceuticals, Inc. $249.66 05/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118266039 Boehringer Ingelheim International GmbH $445.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118266041 Boehringer Ingelheim Pharmaceuticals, Inc. $20.86 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118266043 Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118266045 Boehringer Ingelheim Pharmaceuticals, Inc. $46.46 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118266047 Boehringer Ingelheim Pharmaceuticals, Inc. $73.25 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118266049 Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 07/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118266051 Boehringer Ingelheim International GmbH $209.40 07/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118266053 Boehringer Ingelheim International GmbH $484.73 10/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118266055 Boehringer Ingelheim International GmbH $484.73 12/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118266057 Boehringer Ingelheim International GmbH $505.55 09/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118266059 Boehringer Ingelheim International GmbH $890.00 02/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1147902276 Supernus Pharmaceuticals, Inc. $25.93 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.